IL-17 binding compounds and medical uses thereof

Details for Australian Patent Application No. 2010288542 (hide)

Owner Covagen AG

Inventors Grabulovski, Dragan; Melkko, Michela Silacci; Mourlane, Frederic; Brack, Simon Sebastian; Bertschinger, Julian; Baenziger, Nadja; Batey, Sarah

Agent Shelston IP

Pub. Number AU-A-2010288542

PCT Pub. Number WO2011/023685

Priority 09010950.5 27.08.09 EP

Filing date 24 August 2010

Wipo publication date 3 March 2011

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/023685 Priority application(s): WO2011/023685

17 May 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Grabulovski, Dragan; Silacci Melkko, Michela; Mourlane, Frederic; Brack, Simon Sebastian; Bertschinger, Julian; Baenziger, Nadja and Batey, Sarah

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010288546-Bifidobacterium longum and functional GI disorders

2010288534-Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators